OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
LIVI57

Livingstone Health Holdings Ltd

Healthcare Facilities & ServicesVerified

Livingstone Health Holdings Ltd has a debt-to-equity ratio of 0.87, indicating a moderate level of leverage, and a current ratio of 1.02, suggesting that the company has just enough current assets to cover its current liabilities. The company's liquidity position is assessed as medium, with a key flag indicating that net cash is negative after subtracting total debt. In terms of profitability, the company's return on equity is 8.68%, and its return on assets is 2.79%. These figures are to be compared against the industry's preferred metrics and cohort medians to determine the company's performance relative to its peers. The company's revenue is distributed across three segments: Specialist Healthcare, Primary Healthcare, and Others. The revenue concentration across these segments is not disclosed, but the company's operations are primarily based in Singapore. The company's growth trajectory is not explicitly stated, but the company's recent actual revenue was reported at 191,910,000 SGD, and the last actual EPS was -217.50 SGD. The company's future growth will depend on its ability to increase revenue and improve profitability. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The company's capital structure and financial performance suggest that it is not currently facing significant dilution pressures. The company's financials have not been adjusted for any specific valuation considerations. Recent events related to the company include the latest financial snapshot and risk assessment, which provide insights into the company's current financial position and potential risks. No specific recent filings or transcripts are mentioned in the provided data.

30-day price · LIVI+0.00 (+3.7%)
Low$0.03High$0.03Close$0.03As of17 May, 00:00 UTC
Profile
CompanyLivingstone Health Holdings Ltd
TickerLIVI.SI
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Livingstone Health Holdings Ltd operates as a Singapore-based investment holding company engaged in the provision of medical treatment and consultancy services, operating through three segments: Specialist Healthcare, Primary Healthcare, and Others.

Classification. Livingstone Health Holdings Ltd is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a confidence level of 0.92.

Livingstone Health Holdings Ltd has a debt-to-equity ratio of 0.87, indicating a moderate level of leverage, and a current ratio of 1.02, suggesting that the company has just enough current assets to cover its current liabilities. The company's liquidity position is assessed as medium, with a key flag indicating that net cash is negative after subtracting total debt. In terms of profitability, the company's return on equity is 8.68%, and its return on assets is 2.79%. These figures are to be compared against the industry's preferred metrics and cohort medians to determine the company's performance relative to its peers. The company's revenue is distributed across three segments: Specialist Healthcare, Primary Healthcare, and Others. The revenue concentration across these segments is not disclosed, but the company's operations are primarily based in Singapore. The company's growth trajectory is not explicitly stated, but the company's recent actual revenue was reported at 191,910,000 SGD, and the last actual EPS was -217.50 SGD. The company's future growth will depend on its ability to increase revenue and improve profitability. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The company's capital structure and financial performance suggest that it is not currently facing significant dilution pressures. The company's financials have not been adjusted for any specific valuation considerations. Recent events related to the company include the latest financial snapshot and risk assessment, which provide insights into the company's current financial position and potential risks. No specific recent filings or transcripts are mentioned in the provided data.
Key takeaways
  • Livingstone Health Holdings Ltd has a moderate level of leverage with a debt-to-equity ratio of 0.87.
  • The company's return on equity is 8.68%, indicating a relatively strong return for shareholders.
  • The company's liquidity position is assessed as medium, with a current ratio of 1.02.
  • The company's recent actual revenue was reported at 191,910,000 SGD, and the last actual EPS was -217.50 SGD.
  • The company's risk assessment indicates a medium liquidity risk and a low dilution risk.
  • # RATIONALES
  • margin_outlook_rationale: The company's margin outlook is uncertain due to the negative EPS and the need to improve profitability.
  • rd_outlook_rationale: The company's R&D outlook is not explicitly stated in the provided data.
Financial snapshot
PeriodHA-latest
CurrencySGD
Revenue$27.6M
Gross profit$22.0M
Operating income$70.0k
Net income$556.5k
R&D
SG&A
D&A
SBC
Operating cash flow$4.3M
CapEx-$280.4k
Free cash flow$2.4M
Total assets$20.0M
Total liabilities$13.5M
Total equity$6.4M
Cash & equivalents$3.0M
Long-term debt$5.6M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$6.4M
Net cash-$2.6M
Current ratio1.0
Debt/Equity0.9
ROA2.8%
ROE8.7%
Cash conversion7.7%
CapEx/Revenue-1.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Pharmaceuticals · cohort 25 companies
MetricLIVIActivity
Op margin0.3%18.2% medp25 18.2% · p75 24.6%bottom quartile
Net margin2.0%14.7% medp25 11.7% · p75 28.1%bottom quartile
Gross margin79.6%19.7% medp25 19.7% · p75 39.8%top quartile
R&D / revenue24.3% medp25 6.6% · p75 24.3%
CapEx / revenue-1.0%4.9% medp25 4.2% · p75 6.3%bottom quartile
Debt / equity87.0%71.3% medp25 19.0% · p75 91.7%above median
Observations
IR observations
Last actual EPS-217.50 SGD
Last actual revenue191,910,000 SGD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 20:40 UTC#26a3fdee
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 20:41 UTCJob: f40d4c75